Bayesian Capital Management’s ImmunityBio IBRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-82,100
| Closed | -$519K | – | 847 |
|
|
2024
Q2 | $519K | Buy |
+82,100
| New | +$519K | 0.06% | 361 |
|
|
2022
Q3 | – | Sell |
-47,400
| Closed | -$176K | – | 848 |
|
|
2022
Q2 | $176K | Buy |
47,400
+16,100
| +51% | +$59.8K | 0.03% | 637 |
|
|
2022
Q1 | $176K | Buy |
+31,300
| New | +$176K | 0.03% | 669 |
|